Analyst Ratings For SeaSpine Holdings Corp (NASDAQ:SPNE)
Today, HC Wainwright reiterated its Buy rating on SeaSpine Holdings Corp (NASDAQ:SPNE) with a price target of $15.00.
There are 5 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.
The current consensus rating on SeaSpine Holdings Corp (NASDAQ:SPNE) is Buy with a consensus target price of $18.00 per share, a potential 39.10% upside.
Some recent analyst ratings include
- 7/31/2018-HC Wainwright Reiterated Rating of Buy.
- 7/30/2018-Cantor Fitzgerald Reiterated Rating of Buy.
- 3/2/2018-BTIG Research Reiterated Rating of Buy.
- 12/14/2017-LADENBURG THALM/SH SH initiated coverage with a Buy rating.
- 8/20/2017-Piper Jaffray Companies Reiterated Rating of Buy.
Recent Insider Trading Activity For SeaSpine Holdings Corp (NASDAQ:SPNE)
SeaSpine Holdings Corp (NASDAQ:SPNE) has insider ownership of 13.54% and institutional ownership of 45.81%.
- On 5/18/2018 Keith Bradley, Director, sold 2,609 with an average share price of $11.96 per share and the total transaction amounting to $31,203.64.
- On 11/10/2017 Michael Fekete, Director, bought 1,490 with an average share price of $10.25 per share and the total transaction amounting to $15,272.50.
- On 11/8/2017 Michael Fekete, Director, bought 560 with an average share price of $10.25 per share and the total transaction amounting to $5,740.00.
- On 3/15/2017 Michael Fekete, Director, bought 5,100 with an average share price of $6.65 per share and the total transaction amounting to $33,915.00.
- On 3/13/2017 Patrick L Keran, VP, sold 6,315 with an average share price of $6.66 per share and the total transaction amounting to $42,057.90.
- On 3/13/2017 Stuart Essig, Director, bought 50,000 with an average share price of $6.67 per share and the total transaction amounting to $333,500.00.
- On 11/18/2016 John J Bostjancic, CFO, bought 3,900 with an average share price of $7.02 per share and the total transaction amounting to $27,378.00.
About SeaSpine Holdings Corp (NASDAQ:SPNE)
SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. The company provides orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical regions of the spine. Its orthobiologics products include demineralized bone matrices, collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to enhance bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. The company offers orthobiologics products in various forms, such as putties, pastes, strips, and resorbable mesh. Its spinal implant portfolio comprises products for spinal decompression, alignment, and stabilization that are used to facilitate fusion in minimally invasive, complex, deformity, and degenerative procedures. The company was incorporated in 2015 and is headquartered in Carlsbad, California.
Recent Trading Activity for SeaSpine Holdings Corp (NASDAQ:SPNE)
Shares of SeaSpine Holdings Corp closed the previous trading session at 12,96 +0,71 5,80 % with 5062 shares trading hands.